Literature DB >> 26716458

Proton Pump Inhibitors and the Prescribing Cascade.

Mohammad Rababa, Amal Ali Al-Ghassani, Christine R Kovach, Elaine M Dyer.   

Abstract

ACTIVITY
OBJECTIVES: 1. Describe the prescribing cascade of proton pump inhibitors (PPI) in nursing home residents. 2. Identify the statistically significant factors related to the use of PPI and H2 receptor blockers. DISCLOSURE STATEMENT Neither the planners nor the authors have any conflicts of interest to disclose. The current study examined the use of proton pump inhibitor (PPI) drugs in 248 nursing home residents and factors associated with being prescribed a PPI. Ninety-three percent of residents taking a PPI had done so for longer than recommended durations. As anticholinergic burden, vitamin/supplement use, and number of oral products taken daily increased, residents were more likely to be taking a PPI. Higher anticholinergic burden (p = 0.031) and number of oral products taken daily (p = 0.04) were two statistically significant predictors in the final logistic regression model. Significant predictors of PPI use in the current study may be explained by the association between polypharmacy and dyspepsia and the lowering of esophageal sphincter pressure by anticholinergic drugs. High use of PPIs in nursing home residents may represent a prescribing cascade. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26716458     DOI: 10.3928/00989134-20151218-04

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  7 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia.

Authors:  Shanna C Trenaman; Austin Harding; Susan K Bowles; Susan A Kirkland; Melissa K Andrew
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

3.  The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer.

Authors:  Manvi Sharma; Holly M Holmes; Hemalkumar B Mehta; Hua Chen; Rajender R Aparasu; Ya-Chen T Shih; Sharon H Giordano; Michael L Johnson
Journal:  Cancer       Date:  2019-01-03       Impact factor: 6.860

Review 4.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

5.  Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients.

Authors:  Panagiota Voukelatou; Ioannis Vrettos; Georgia Emmanouilidou; Konstantinos Dodos; Georgia Skotsimara; Dimitra Kontogeorgou; Andreas Kalliakmanis
Journal:  Curr Gerontol Geriatr Res       Date:  2019-01-01

6.  Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.

Authors:  Mohammad Rababa; Abeer Rababa'h
Journal:  BMC Geriatr       Date:  2020-10-29       Impact factor: 3.921

7.  The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults.

Authors:  Mohammad Rababa; Abeer Rababa'h
Journal:  Heliyon       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.